Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria

E J Lesnefsky1, T J Slabe, M S Stoll

  • 1Division of Cardiology, Case Western Reserve University, Cleveland, Ohio 44106, USA. EXL9@po.cwru.edu

Insights

Mitochondrial cardiolipin loss during ischemia impairs oxidative phosphorylation in subsarcolemmal mitochondria (SSM), contributing to heart injury. Interfibrillar mitochondria (IFM) remain protected, highlighting differential mitochondrial vulnerability.

Area of Science:

  • Cardiovascular Science
  • Mitochondrial Biology
  • Ischemic Pathophysiology

Background:

  • Mitochondria are crucial for myocyte injury during ischemia.
  • Subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM) exhibit distinct responses to ischemia.

Purpose of the Study:

  • To investigate the differential impact of ischemia on mitochondrial subpopulations.
  • To identify early molecular targets of ischemic damage in cardiac mitochondria.

Main Methods:

  • Isolated perfused rabbit heart model subjected to 30 and 45 minutes of ischemia.
  • Assessment of oxidative phosphorylation via cytochrome oxidase activity in SSM and IFM.
  • Analysis of phospholipid and cardiolipin content in isolated mitochondrial subpopulations.

Main Results:

  • Ischemia significantly decreased oxidative phosphorylation in SSM but not IFM.
  • Cardiolipin content specifically decreased in SSM during ischemia.
  • Other phospholipids remained preserved, and cardiolipin composition in SSM was unaltered.

Conclusions:

  • Cardiolipin is an early molecular target of ischemic damage in cardiac mitochondria.
  • Selective cardiolipin depletion in SSM leads to impaired oxidative phosphorylation and contributes to myocyte injury.
  • Differential vulnerability of SSM and IFM to ischemia is linked to cardiolipin content.

Related Concept Videos